坎伯蘭藥業 CPIX 深 滬
等待開盤 11-04 09:30:00 美东时间
4.31
+0.090
+2.13%
華盛通- 最 高4.42
- 今 開4.28
- 成交量 21.52万股
- 最 低 4.17
- 昨 收 4.22
- 總市值 6457.72万
- 52周最高 9.2799
- 市盈率 靜 --
- 換手率 1.44%
- 52周最低 0.35
- 委 比 99.00%
- 總股本 1498.31万
- 歷史最高 9.2799
- 量 比 0.97
- 振 幅 5.92%
- 歷史最低 -0.46
- 每 手 1
- 風險率 2.38%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTS
NASHVILLE, Tenn., Nov. 3, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation-focused biopharmaceutical company committed to developing new products for rare d...
今天 05:05
坎伯兰药业收跌10.02%，成交额90.37万美元
11月3日，坎伯兰药业（CPIX）收跌10.02%，报4.22美元，成交额90.37万美元，市值6322.87万美元。 行情数据 • 开盘价：4.59美元 •...
11-03 08:14
坎伯兰药业收跌48.76%，成交额254.3万美元
10月27日，坎伯兰药业（CPIX）收跌48.76%，报4.35美元，成交额254.3万美元，市值6517.62万美元。 行情数据 • 开盘价：7.76美元 ...
10-27 07:16
Cumberland to Submit NDA for Ifetroban DMD Therapy
Cumberland Pharmaceuticals ( ($CPIX) ) has provided an update. On October 26, 2...
10-27 04:57
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
Spero Therapeutics appoints Amy Rock, Ph.D., as Chief Regulatory and Quality Officer and Dae Gon Ha, Ph.D., as Senior Vice President, Corporate Development. Rock brings over 25 years of experience in regulatory affairs and immunotherapy development, while Ha has expertise in biopharma markets and business development. Additionally, Chief Operating Officer Timothy Keutzer will retire after 11 years, during which he played a key role in advancing U...
10-26 12:00
Cumberland Reports Positive Phase 2a Ifetroban Safety Results
Cumberland Pharmaceuticals ( ($CPIX) ) just unveiled an update. On October 23, ...
10-24 05:29
Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results
Ifetroban was well tolerated in patients with systemic sclerosis NASHVILLE, Tenn., Oct. 23, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), an innovation-driven biopharm...
10-24 04:05
CUMBERLAND PHARMACEUTICALS PROVIDES UPDATED WEBCAST REGISTRATION LINK FOR IFETROBAN DMD PROGRAM CALL
NASHVILLE, Tenn., Oct. 23, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation-driven biopharmaceutical company advancing new therapies that address significan...
10-23 21:05
坎伯兰药业收跌4.77%，成交额62.99万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:05
Cumberland Pharmaceuticals Updates Ifetroban DMD Trial Timeline
The latest announcement is out from Cumberland Pharmaceuticals ( ($CPIX) ). On ...
08-29 05:31
